Celgene Corporation
Celgene Corporation, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1986, the company has made significant strides in developing innovative therapies, particularly in the fields of oncology and immunology. Celgene is renowned for its core products, including Revlimid and Pomalyst, which have transformed treatment protocols for various blood cancers.
With a strong presence in North America, Europe, and Asia, Celgene has established itself as a leader in the biopharmaceutical sector. The company’s commitment to research and development has led to numerous breakthroughs, positioning it as a key contributor to advancements in personalised medicine. Notable achievements include its acquisition by Bristol-Myers Squibb in 2019, further solidifying its market position and expanding its reach in the global healthcare landscape.
+38 vs industry average
Celgene Corporation’s score of 76 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Celgene Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Celgene Corporation yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Celgene Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Celgene Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Bristol-Myers Squibb Company
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Bristol-Myers Squibb CompanyRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project